Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1/BRCA2 during adulthood: description of an emerging phenotype
- 25 October 2021
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 59 (9) , 912-915
Abstract
Fanconi anaemia due to biallelic loss of BRCA2 (Fanconi anaemia subtype D1) is traditionally diagnosed during childhood with cancer rates historically reported as 97% by 5.2 years. This report describes an adult woman with a history of primary ovarian failure, who was diagnosed with gastrointestinal adenocarcinoma and BRCA2-associated Fanconi anaemia at 23 years of age, only after she suffered severe chemotherapy toxicity. The diagnostic challenges include atypical presentation, initial false-negative chromosome fragility testing and variant classification. It highlights gastrointestinal adenocarcinoma as a consideration for adults with biallelic BRCA2 pathogenic variants with implications for surveillance. After over 4 years, the patient has no evidence of gastrointestinal cancer recurrence although the tumour was initially considered only borderline resectable. The use of platinum-based chemotherapy, to which heterozygous BRCA2 carriers are known to respond, may have had a beneficial anticancer effect, but caution is advised given its extreme immediate toxicity at standard dosing. Fanconi anaemia should be considered as a cause for women with primary ovarian failure of unknown cause and referral to cancer genetic services recommended when there is a family history of cancer in the hereditary breast/ovarian cancer spectrum.Keywords
Funding Information
- Cancer Institute NSW (ID 2018_03)
- Sydney Catalyst
- National Health and Medical Research Council (ID 1177524)
This publication has 18 references indexed in Scilit:
- Whole-exome sequencing is a powerful approach for establishing the etiological diagnosis in patients with intellectual disability and microcephalyBMC Medical Genomics, 2015
- Central nervous system abnormalities in Fanconi anaemia: patterns and frequency on magnetic resonance imagingBritish Journal of Radiology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Exceptions to the rule: Case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genesClinical Genetics, 2015
- Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 geneEuropean Journal of Human Genetics, 2013
- Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyBritish Journal of Cancer, 2013
- Fanconi anemia and its diagnosisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2009
- Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2Journal of Medical Genetics, 2006
- Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon CancerNew England Journal of Medicine, 2004
- Biallelic Inactivation of BRCA2 in Fanconi AnemiaScience, 2002